You are now leaving arenapharm.com and being directed to a site not maintained by Arena. Arena is not responsible for content or privacy policies on other sites.
Cancel Ok

Partnerships

EXPLORING ALL POSSIBILITIES

Arena Pharmaceuticals is advancing multiple assets and taking every opportunity to develop important medicines* for patients. We will keep pushing forward . . . until it’s done.
Project Cabrillo
Early Stage Immune & Inflammatory Platform w/Beacon
Target 1
Early Research
Target 2
Early Research
Additional Targets
Early Research
Multiple Assets
Longboard
LP352
Phase 1
LP143
Preclinical
LP659
Early Research
Additional Targets
Early Research
UNDISCLOSED ORPHAN GPCR
Boehringer Ingelheim
Central Nervous System
Preclinical
RALINEPAG
United Therapeutics
Pulmonary Arterial Hypertension
Phase 3
*Arena is a clinical stage pharmaceutical company that does not have any medicines or products approved for use by any health authority.